Compound-compound Interaction Analysis of Baicalin and Berberine Derivatives in Aqueous Solution

Overview

Journal J Nat Med

Publisher Springer

Date 2024 Apr 4

PMID 38573419

Authors

Yoshinori Uekusa

Chiharu Tanioka

Kenjiro Nakamoto

Riina Tsutsumi

Chihiro Iida

Naoto Enshu

Takehiro Nishimura

Fumiyuki Kiuchi

Haruhisa Kikuchi

Affiliations

Soon will be listed here.

Abstract

Baicalin and berberine are biologically active constituents of the crude drugs Scutellaria root and Coptis rhizome/Phellodendron bark, respectively. Baicalin and berberine are reported to combine together as a 1:1 complex that forms yellow precipitates by electrostatic interaction in decoctions of Kampo formulae containing these crude drugs. However, the structural basis and mechanism for the precipitate formation of this compound-compound interaction in aqueous solution remains unclarified. Herein, we searched for berberine derivatives in the Coptis rhizome that interact with baicalin and identified the chemical structures involved in the precipitation formation. Precipitation assays showed that baicalin formed precipitates with berberine and coptisine but not with palmatine and epiberberine. Thus, the 2,3-methylenedioxy structure may be crucial to the formation of the precipitates, and electrostatic interaction is necessary but is not sufficient. In this multicomponent system experiment, palmatine formed a dissociable complex with baicalin and may competitively inhibit the formation of berberine and coptisine precipitation with baicalin. Therefore, the precipitation formed by berberine and baicalin was considered to be caused by the aggregation of the berberine-baicalin complex, and the 2,3-methylenedioxy structure is likely crucial to the aggregation of the complex.

References

Ishizu T, Hirata C, Yamamoto H, Harano K . Structure and intramolecular flexibility of beta-cyclodextrin complex with (-)-epigallocatechin gallate in aqueous solvent. Magn Reson Chem. 2006; 44(8):776-83. DOI: 10.1002/mrc.1848. View

Oshima N, Shimizu T, Narukawa Y, Hada N, Kiuchi F . Quantitative analysis of the anti-inflammatory activity of orengedokuto II: berberine is responsible for the inhibition of NO production. J Nat Med. 2018; 72(3):706-714. DOI: 10.1007/s11418-018-1209-7. View

Qi Y, Zhang Q, Zhu H . Huang-Lian Jie-Du decoction: a review on phytochemical, pharmacological and pharmacokinetic investigations. Chin Med. 2019; 14:57. PMC: 6918586. DOI: 10.1186/s13020-019-0277-2. View

Li Z, Liu Y, Wang J, Feng X, Nwafor E, Zhang Y . Baicalin-berberine complex nanocrystals orally promote the co-absorption of two components. Drug Deliv Transl Res. 2022; 12(12):3017-3028. DOI: 10.1007/s13346-022-01167-w. View

Xue B, Chen X, Wang X, Li C, Liu J, He Q . Application of multivariate statistical analysis and network pharmacology to explore the mechanism of Danggui Liuhuang Tang in treating perimenopausal syndrome. J Ethnopharmacol. 2021; 284:114543. DOI: 10.1016/j.jep.2021.114543. View

Okoshi K, Uekusa Y, Narukawa Y, Kiuchi F . Solubility enhancement of berberine-baicalin complex by the constituents of Gardenia Fruit. J Nat Med. 2020; 75(1):76-83. PMC: 8933372. DOI: 10.1007/s11418-020-01446-1. View

Zhang C, Zhao R, Yan W, Wang H, Jia M, Zhu N . Compositions, Formation Mechanism, and Neuroprotective Effect of Compound Precipitation from the Traditional Chinese Prescription Huang-Lian-Jie-Du-Tang. Molecules. 2016; 21(8). PMC: 6272921. DOI: 10.3390/molecules21081094. View

Yang F, Zhang T, Zhang R, Ito Y . Application of analytical and preparative high-speed counter-current chromatography for separation of alkaloids from Coptis chinensis Franch. J Chromatogr A. 1999; 829(1-2):137-41. DOI: 10.1016/s0021-9673(98)00776-6. View

Cheng Z, Chen A, Wu F, Sheng L, Zhang H, Gu M . 8,8-Dimethyldihydroberberine with improved bioavailability and oral efficacy on obese and diabetic mouse models. Bioorg Med Chem. 2010; 18(16):5915-24. DOI: 10.1016/j.bmc.2010.06.085. View

10.

Wu J, Lei F, Cui X, He Y, Hai L, Zhang J . Design, synthesis and multidrug resistance reversal activity evaluation of 8-oxocoptisine derivatives. Med Chem. 2012; 8(4):742-8. DOI: 10.2174/157340612801216148. View

11.

Tajiri M, Yamada R, Hotsumi M, Makabe K, Konno H . The total synthesis of berberine and selected analogues, and their evaluation as amyloid beta aggregation inhibitors. Eur J Med Chem. 2021; 215:113289. DOI: 10.1016/j.ejmech.2021.113289. View

12.

Zhang Y, Wang C, Wang L, Parks G, Zhang X, Guo Z . A novel analgesic isolated from a traditional Chinese medicine. Curr Biol. 2014; 24(2):117-123. PMC: 3912990. DOI: 10.1016/j.cub.2013.11.039. View

13.

Liu H, Wang L, Li Y, Liu J, An M, Zhu S . Structural optimization of berberine as a synergist to restore antifungal activity of fluconazole against drug-resistant Candida albicans. ChemMedChem. 2013; 9(1):207-16. DOI: 10.1002/cmdc.201300332. View

14.

Li Y, Yang P, Kong W, Wang Y, Hu C, Zuo Z . Berberine analogues as a novel class of the low-density-lipoprotein receptor up-regulators: synthesis, structure-activity relationships, and cholesterol-lowering efficacy. J Med Chem. 2008; 52(2):492-501. DOI: 10.1021/jm801157z. View

15.

Li Y, Li Y, Yang P, Kong W, You X, Ren G . Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubine. Bioorg Med Chem. 2010; 18(17):6422-8. DOI: 10.1016/j.bmc.2010.06.106. View

16.

Jung H, Yoon N, Bae H, Min B, Choi J . Inhibitory activities of the alkaloids from Coptidis Rhizoma against aldose reductase. Arch Pharm Res. 2008; 31(11):1405-12. DOI: 10.1007/s12272-001-2124-z. View